PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation

PRCT·NASDAQ

$26.84

+0.31%
HealthcareMedical - Devices

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

At a Glance

Live Snapshot
Market Cap$1.53B
EPS-1.7200
P/E Ratio-15.61
Earnings Date08/05/2026

prct

Account Payables

Last Annual Value

17.29M

3-Year CAGR

23%

5-Year CAGR

69%

10-Year CAGR

28%

PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation Competitors Analysis of Account Payables

PRCT · NASDAQ
CompanyAccount Payables
CAGR 3Y
CAGR 5Y
CAGR 10Y
17.29M
8.6%53.5%N/A 
5.13M
78.5%110.3%57.4%
116.21M
10.7%12.5%N/A
279.40M
-1.8%22.4%33.1%
11.09M
-7.6%-5.7%16.9%
6.01M
14.3%9.3%N/A
16.04M
6.4%9.1%10.8%
153.25M
60.3%40.4%N/A
36.56M
-2.0%25.7%41.1%
PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation Fair Value Envelope

PRCT · NASDAQ

Our analysis suggests that PRCT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $26.8428, this represents a potential HIDDEN relative to our calculated worth for PROCEPT BioRobotics Corporation.

Intrinsic Value
Current Price: $26.8428